UBS Declares Quarterly Coupon Payment on Exchange-Traded Note: AMU
20 11월 2014 - 12:00AM
Business Wire
UBS Investment Bank today announced a coupon payment for
the ETRACS Alerian MLP Index ETN (NYSE Arca: “AMU”). The relevant
coupon information is provided in the table below. For additional
ETRACS information, go to www.etracs.com or download the ETRACS
Full ETN List.
NYSE ETN Valuation
Ex- Record Payment
Coupon Payment Current Yield*
Ticker Name Date
Date Date Date
Amount Schedule (annualized) AMU
ETRACS Alerian MLP
Index ETN
11/17/14 11/26/14 12/01/14 12/09/14 $0.3778 Quarterly 4.68%
* "Current Yield (annualized)" equals the current Coupon Amount,
multiplied by four (to annualize such coupon), divided by the
closing price of the ETN on its current Coupon Valuation Date, or,
if the closing price is not available on that date, then the
previous available closing price, and rounded to two decimal places
for ease of analysis. The Current Yield is not indicative of future
coupon payments, if any, on the ETN. You are not guaranteed any
coupon or distribution amount under the ETN.
About ETRACS
ETRACS ETNs are exchange-traded notes, an innovative class of
investment products offering access to markets and strategies that
may not be readily available to investors, and offer unique
diversification opportunities in a number of different sectors.
ETRACS ETNs may offer:
- Access to asset classes with
historically low correlations to more traditional asset
classes
- Convenience of an exchange-traded
security
- Transparent exposure to a published
index
ETRACS ETNs are senior unsecured notes issued by UBS AG, are
traded on NYSE Arca, and can be bought and sold through a broker or
financial advisor. An investment in ETRACS ETNs is subject to a
number of risks, including the risk of loss of some or all of the
investor’s principal, and is subject to the creditworthiness of UBS
AG. You are not guaranteed any coupon or distribution amount under
the ETNs. We urge you to read the more detailed explanation
of risks described under “Risk Factors” in the prospectus
supplement for the ETRACS ETN.
This communication is issued by UBS AG or an affiliate thereof
("UBS"). Products and services in this communication may not be
available for residents of certain jurisdictions.
In the United States, this communication is issued by UBS
Securities LLC (member FINRA, NYSE and SIPC) or UBS Financial
Services Inc. (member FINRA and SIPC), subsidiaries of UBS AG, or
solely to qualified US institutional investors by UBS AG or a
subsidiary or affiliate thereof that is not registered as a US
broker-dealer (a "non-US affiliate"). Transactions resulting from
materials distributed by a non-US affiliate must be effected
through UBS Securities LLC or UBS Financial Services Inc.
Neither UBS nor any of its directors, officers, employees or
agents accepts any liability for any loss or damage arising out of
the use of all or any part of this communication or reliance upon
any information contained herein.
ETRACS ETNs are sold only in conjunction with the relevant
offering materials. UBS has filed a registration statement
(including a prospectus, as supplemented by a prospectus
supplement, or product supplement and pricing supplement, for the
offering of the ETRACS ETNs) with the Securities and Exchange
Commission (the "SEC") for the offering to which this communication
relates. Before you invest, you should read these documents and any
other documents that UBS has filed with the SEC for more complete
information about UBS and the offering to which this communication
relates. You may get these documents for free by visiting EDGAR on
the SEC website at www.sec.gov. Alternatively, you can request the
prospectus and the prospectus supplement, or applicable product
supplement and pricing supplement, by calling toll-free (+1-877-387
2275). In the US, securities underwriting, trading and brokerage
activities and M&A advisor activities are provided by UBS
Securities LLC, a registered broker/dealer that is a wholly owned
subsidiary of UBS AG, a member of the New York Stock Exchange and
other principal exchanges, and a member of SIPC. UBS Financial
Services Inc. is a registered broker/dealer and affiliate of UBS
Securities LLC.
UBS specifically prohibits the redistribution or reproduction of
this communication in whole or in part without the prior written
permission of UBS and UBS accepts no liability whatsoever for the
actions of third parties in this respect. © UBS 2014. The key
symbol, UBS and ETRACS are among the registered and unregistered
trademarks of UBS. Alerian MLP Index, Alerian MLP Total Return
Index, AMZ, and AMZX are trademarks of Alerian and their use is
granted under a license from Alerian. Other marks may be trademarks
of their respective owners. All rights reserved.
Notes to Editors
UBS draws on its 150-year heritage to serve private,
institutional and corporate clients worldwide, as well as retail
clients in Switzerland. Its business strategy is centered on its
pre-eminent global wealth management businesses and its leading
universal bank in Switzerland, complemented by its Global Asset
Management business and its Investment Bank, with a focus on
capital efficiency and businesses that offer a superior structural
growth and profitability outlook.
UBS is present in all major financial centers worldwide. It has
offices in more than 50 countries, with about 35% of its employees
working in the Americas, 36% in Switzerland, 17% in the rest of
Europe, the Middle East and Africa and 12% in Asia Pacific. UBS
employs about 60,000 people around the world. Its shares are listed
on the SIX Swiss Exchange and the New York Stock Exchange
(NYSE).
Media EnquiriesUBS AGNew York:Azar Boehm,
+1-212-713-3379orMegan Stinson, +1-212-713-1302
Follow us on Twitter at: www.ubs.com/twitteramericas
THC Farmaceuticals (PK) (USOTC:CBDG)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
THC Farmaceuticals (PK) (USOTC:CBDG)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024